SciClone Pharmaceuticals (02291.HK) repurchased 47,000 shares for HKD 519,200 on September 15.

Zhito Finance APP News: Xintai Medical (02291.HK) announced that on September 15, 2026, the company spent HK$519,200 to repurchase 47,000 shares at a repurchase price of HK$10.95-11.2 per share.